The GPR171 pathway suppresses T cell activation and limits antitumor immunity

Yuki Fujiwara(University of Colorado Anschutz Medical Campus), Yuwen Zhu(University of Colorado Anschutz Medical Campus)
Nature Communications
October 6, 2021
Cited by 31


Related Papers